NCT05949632View on ClinicalTrials.gov

A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

June 6, 2025

Study Completion Date

June 6, 2025

Conditions
Advanced Solid Tumors
Interventions
DRUG

INCB099280

Administered as specified in the treatment arm description

DRUG

axitinib

Administered as specified in the treatment arm description

Trial Locations (6)

CB2 0QQ

Addenbrookes Hospital, Cambridge

G12 0YN

Beatson West of Scotland Cancer Centrewester, Glasgow

EC1A 7BE

St Bartholomew'S Hospital, London

SE1 9RT

Guys Hospital, London

SW3 6JJ

The Royal Marsden, London

SM2 5PT

The Royal Marsden Nhs Foundation Trust - Sutton, Sutton

Sponsors

Lead Sponsor

Incyte Corporation
All Listed Sponsors
lead

Incyte Corporation

INDUSTRY